Grants and Contributions:
Agreement Number:
-
Agreement Value:
$135,000.00
Agreement Date:
Apr 1, 2017 - Mar 31, 2020
Description:
Oncolytic rhabdovirus vaccines as an adjuvant to adoptive T cell therapy for paediatric metastatic rhabdomyosarcomas: Precision targeting, expansion and trafficking
Organization:
Canadian Institutes of Health Research
Location:
Calgary, Alberta, CA T2N 1N4
Reference Number:
236-2017-2018-Q1-00352
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:
Grant or Award spanning more than one fiscal year.
(2017-18 to 2019-20)
Start date may be subject to change. Funding for awards must commence within 12 months of the date of offer.
Recipient's Legal Name:
Zemp, Franz J
Research Organization:
University of Calgary